Transcript : CS Medica A/S, Q4 2023 Earnings Call, Apr 12, 2024

Equities

CSMED

DK0061668225

End-of-day quote NORDIC GROWTH MARKET Other stock markets 23:00:00 13/05/2024 BST			5-day change	1st Jan Change
6.84 ^DKK	-2.88%		+10.56%	+46.06%

04-30	CS Medica A/S Enters New Partnership with OTC Company Holding A Strong Position in the Chronic Pain Segment in Germany	CI
04-22	CS Medica A/S Advances Global Reach with 180° Drug Store Alliance, Powered by Pull Market Strategy	CI

Presenter SpeechMikkel Nielsen (Executives)Hello, and welcome to this presentation and Q&A wit...

This article is reserved for subscribers

Signed up already?

Not subscribed yet?

Latest news about CS MEDICA A/S

CS Medica A/S Enters New Partnership with OTC Company Holding A Strong Position in the Chronic Pain Segment in Germany	04-30	CI
CS Medica A/S Advances Global Reach with 180° Drug Store Alliance, Powered by Pull Market Strategy	04-22	CI
Transcript : CS Medica A/S, Q4 2023 Earnings Call, Apr 12, 2024	04-12
CS Medica A/S Breaks Through Asian Market Barrier with Approval of Protective Nasal Gel in Malaysia	04-04	CI
Transcript : CS Medica A/S, 2023 Earnings Call, Feb 21, 2024	02-21
CS MEDICA A/S Partners with New Distributor to Launch CANNASEN into Jordan	02-20	CI
CS Medica Obtains Danish Patent for Wound Healing Gel	02-02	MT
CS Medica Set to Launch Pain Patch, Cosmetic Products in Australia	01-26	MT
CS Medica A/S Announces FDA Authorization for Commercialization for Eight Products in the U.S. Market	12-27	CI
Transcript : CS Medica A/S, Q4 2023 Earnings Call, Dec 05, 2023	12-05
CS Medica A/S Announces Financial Year Change	11-22	CI
CS Medica A/S Reports Earnings Results for the Fourth Quarter Ended September 30, 2023	11-22	CI
CS Medica A/S Reports Earnings Results for the Full Year Ended September 30, 2023	11-22	CI
CS Medica's Nasal Protect Gel Secures Second Patent in Denmark	31/10/23	MT
Cs Medica A/S Announces Indian State's Fda Approval for Two Cosmetic Products	12/10/23	CI
Danske Bank Extends DKK 1.2 Million Credit Line to CS MEDICA	10/10/23	CI
CS Medica A/S Reports Earnings Results for the Third Quarter and Nine Months Ended June 30, 2023	13/09/23	CI
CS Medica Secures Denmark Patent for Nasal Spray	30/08/23	MT
Transcript : CS Medica A/S, Q3 2023 Earnings Call, Aug 08, 2023	08/08/23
CS MEDICA A/S Announces Establishment of CANNORDIC India Pvt. Ltd. to Expand Presence in India	14/07/23	CI
CS Medica A/S Signs New Own-Label Agreement on Pain Patch	21/06/23	CI
CS Medica Signs Deal for Future Compliance for CE-marked Medical Devices with CBD in EU	15/06/23	MT
CS MEDICA A/S Secures Future Compliance with New Medical Device Regulation Through Signed Contract with Notify Body	15/06/23	CI
CS Medica A/S Secures Future Compliance with New Medical Device Regulation Through Signed Contract with Notify Body	15/06/23	CI
CS Medica A/S Announces Positive Results from Clinical Trial of Nasal Protect Gel for Hay Fever/Allergic Rhinitis	08/05/23	CI

Chart CS MEDICA A/S

Duration

Period

More charts

Company Profile

Sector

More about the company

Income Statement Evolution

More financial data

Annual profits - Rate of surprise

Company calendar